Addex Therapeutics (ADXN) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $64062.6.
- Addex Therapeutics' Receivables - Net fell 8843.69% to $64062.6 in Q3 2025 from the same period last year, while for Sep 2025 it was $64062.6, marking a year-over-year decrease of 8843.69%. This contributed to the annual value of $17633.7 for FY2024, which is 8564.98% down from last year.
- Latest data reveals that Addex Therapeutics reported Receivables - Net of $64062.6 as of Q3 2025, which was down 8843.69% from $46430.1 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Receivables - Net ranged from a high of $647893.3 in Q2 2024 and a low of $17708.4 during Q4 2024
- Moreover, its 4-year median value for Receivables - Net was $249113.9 (2023), whereas its average is $256782.7.
- Per our database at Business Quant, Addex Therapeutics' Receivables - Net surged by 16557.08% in 2024 and then crashed by 9283.37% in 2025.
- Over the past 4 years, Addex Therapeutics' Receivables - Net (Quarter) stood at $432725.3 in 2022, then tumbled by 71.25% to $124416.0 in 2023, then plummeted by 85.77% to $17708.4 in 2024, then skyrocketed by 261.76% to $64062.6 in 2025.
- Its last three reported values are $64062.6 in Q3 2025, $46430.1 for Q2 2025, and $39330.3 during Q1 2025.